National Institute of Cancer

Kyiv 03022

0 studies enrolling now · 6 studies all time

What they study most

B-cell Non-Hodgkin's Lymphoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Pancreatic Ductal, Chemotherapy-Induced Nausea and Vomiting, Colorectal Neoplasms, DLBCL Transformed From Indolent Lymphoma, Diffuse Large B-Cell Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Grade 3 Lymphoma, de Novo DLBCL

Studies at this site

• Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Participants With Relapsed and/or Refractory DLBCL and Other Forms of NHL — Completed
• A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma — Completed
• Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant — Completed
• Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer — Completed
• Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer — Completed
• Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients — Completed